Following First-in-Man study success, Ovalum Ltd. launches a multicenter study using the CiTop™ technology in the coronary arteries. Ovalum Ltd., a privately held Israeli medical device company, has announced today successful experiences using CiTop™ ExPander™ Guidewire in traversing chronic total

The Federal Government has inaugurated a seven-man committee for the establishment of Science and Technology Development Fund (STDF).

The author of the best researched article that appeared in the re-established Rwanda Medical Journal will receive an award at the July 10-11 international conference on cardiovascular diseases in Kigali. This prize was pledged at the journal's launch last year.

infoQuant, Ltd. announced today that it joined the Illumina Connect bioinformatics program and is proud to provide state-of-the-art copy number analysis of Illumina array data. Through Illumina Connect infoQuant's advanced copy number solutions will deliver a seamless experience to Illumina

How far we've come in the past five years, from the days in which the mainstream media poured scorn on the practice of calorie restriction. If there is a lesson here, it is to observe the way in which the

A research group is proposing that buildup of advanced glycation end-products (AGEs) causes DNA damage in addition to known other issues: "The scientists studied semen samples from men with diabetes who were receiving insulin therapy. ... when we looked for

Via EurekAlert!, advocacy from those who believe that engineering metabolism to slow the accumulation of age-related damage is the only way ahead: "The traditional medical approach of attacking individual diseases -- cancer, diabetes, heart disease, Alzheimer's disease and Parkinson's disease

Anne C. ponders long-term maintenance of the brain: "One of the most fascinating things about the brain is how it must simultaneously change constantly over time (in response to new information and other inputs) and maintain the aspects of its